502: Keeping Your Plan in Hand | Mark Guerin, CFO, Onconova Therapeutics, Inc.
Twenty four months ago CFO Mark Guerin had a pretty clear notion of what he wanted Onconova’s financial footing to look like during the second half of 2019. However, the question that lingered was whether the plan Guerin and his team were putting in motion had the vigor to overcome the obstacles along the way.
Beginning with a strongly worded May 2017 message from NASDAQ claiming that Onconova’s stockholder equity was no longer sufficient to meet its listing standards. While Guerin’s plan included two new stock offerings and growing the firm’s stockholder equity – NASDAQ rejected Onconova’s…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.